Provided by Tiger Trade Technology Pte. Ltd.

DIMERIX LTD

0.280
+0.0051.82%
Volume:1.37M
Turnover:372.04K
Market Cap:168.11M
PE:-5.63
High:0.280
Open:0.280
Low:0.260
Close:0.275
52wk High:0.665
52wk Low:0.157
Shares:600.40M
Float Shares:467.70M
Volume Ratio:1.57
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.050
EPS(LYR):-0.024
ROE:-594.54%
ROA:-28.84%
PB:-11.39
PE(LYR):-11.84

Loading ...

Company Profile

Company Name:
DIMERIX LTD
Exchange:
ASX
Establishment Date:
- -
Employees:
15
Office Location:
425 Smith Street,Fitzroy,Victoria,Australia
Zip Code:
3065
Fax:
61 8 9388 8256
Introduction:
Dimerix Limited, a clinical stage biotechnology company, develops and commercializes new therapies in the area of unmet medical needs. Its lead product candidate is DMX-200, which is in Phase II clinical trial for the treatment of diabetic kidney diseases and focal segmental glomerulosclerosis. The company is headquartered in Fitzroy, Australia.